Bioguided Fractionation of Local Plants against Matrix Metalloproteinase9 and Its Cytotoxicity against Breast Cancer Cell Models: In Silico and In Vitro Study (Part II).

In our previous work, the partitions (1 mg/mL) of (AC) aerial parts and (IC) leaves showed inhibitions of 94% and 96%, respectively, whereas their fractions showed IC 43 and 116 µg/mL, respectively, toward Matrix Metalloproteinase9 (MMP9), an enzyme that catalyzes a proteolysis of extracellular matrix. In this present study, we performed IC determinations for AC -hexane, IC -hexane, and IC ethylacetate partitions, followed by the cytotoxicity study of individual partitions against MDA-MB-231, 4T1, T47D, MCF7, and Vero cell lines. Successive fractionations from AC -hexane and IC ethylacetate partitions led to the isolation of two compounds, oxytetracycline (OTC) and dioctyl phthalate (DOP). The result showed that AC -hexane, IC -hexane, and IC ethylacetate partitions inhibit MMP9 with their respective IC as follows: 246.1 µg/mL, 5.66 µg/mL, and 2.75 × 10 µg/mL. Toward MDA-MB-231, 4T1, T47D, and MCF7, AC -hexane demonstrated IC 2.05, 265, 109.70, and 2.11 µg/mL, respectively, whereas IC ethylacetate showed IC 1.92, 57.5, 371.5, and 2.01 µg/mL, respectively. The inhibitions toward MMP9 by OTC were indicated by its IC 18.69 µM, whereas DOP was inactive. A molecular docking study suggested that OTC prefers to bind to PEX9 rather than its catalytic domain. Against 4T1, OTC showed inhibition with IC 414.20 µM. In conclusion, this study furtherly supports the previous finding that AC and IC are two herbals with potential to be developed as triple-negative anti-breast cancer agents.